The life and times of a GSK patent
Carl Battle has a big job on his hands managing pharmaceutical giant GlaxoSmithKline’s patent team. Michael Loney talks to him and some of his staff about bringing Anoro Ellipta to market, the dreaded patent cliff, combating generic drug companies and navigating developing countries’ IP hostility
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
